Prof. Suhail Raoof (Cornell University, NY, USA)
Director, Lenox Hill Hospital and Program Director, Pulmonary and Critical Care Medicine Fellowship at NYM. Professor of clinical medicine at Weill Medical College of Cornell University and the author of numerous articles in the areas of pulmonary and critical care medicine, chest radiology and mechanical ventilation. Past President of the American College of Chest Physicians (CHEST) – the largest group of chest physicians in the world.
Prof. Alexander Gallus (Flinders University, SA)
Professor of Haematology at Flinders University School of Medicine and the Director of Pathology Services at Flinders Medical Centre and the Repatriation General Hospital, Adelaide, Australia, with long-standing research involvement in the diagnosis, prevention and treatment of venous thrombosis and pulmonary embolism. His present research activities centre on international thrombosis treatment trials in collaboration with teams in Europe and North America.
Prof. Robert Heddle (Adelaide University, SA)
Head of Clinical Immunology IMVS/RAH and Chief Pathologist, IMVS. Active in professional associations including roles as President of ASCIA, Specialty Advisory Board RACP, TSANZ Working Party on Omalizumab, ongoing roles as Convener of RCPA QAP in Allergy, Chairperson of SA IVIG Users’ Group, and active roles in ASCIA Anaphylaxis Working Party, ASCIA Insect Allergy Working Party and MAC for Asthma SA.
Prof. Eli Gabbay (University of Notre Dame, WA)
Professor of Respiratory Medicine and Chair of Research at The University of Notre Dame Medical School. Clinical Professor at The University of Western Australia Medical School and Associate Professor at Curtin University School of Physiotherapy. Head of the Advanced Lung Disease and Pulmonary Vascular Unit at the Institute for Respiratory Health. Professor Gabbay was an inaugural board member of the PHSANZ, (Pulmonary Hypertension Society of Australia and New Zealand) and has served as a chair of the Australian Lung Foundation Expert Committee on management of Pulmonary Hypertension.
Prof. Gary Anderson(University of Melbourne, Victoria)
A tenured Professor and Director of the Centre for Lung Health Research. Gary’s own research has centred on using genetic disease models to understanding molecular mechanisms of disease induction, progression, severity and exacerbation in asthma and COPD. As pharmacologist and immunologist he co-discovered the role of Fas in lung inflammation, IL-4 in immune biasing in asthma models and the bronchoprotective PAR receptor system in the airway epithelium.
Prof. Nikolai Petrovsky (Flinders University, SA)
Professor of Medicine at Flinders University of South Australia. Director of Endocrinology at Flinders Medical Centre. Founder and Research Director of Vaxine Pty Ltd. Secretary-General of the International Immunomics Society. Main areas of research interest: immunoinformatics, vaccinology and autoimmune diseases. Active in translational research taking four novel vaccines from the lab to human clinical trials, including the world’s first recombinant H1N1/2009 pandemic vaccine.
Prof. David Currow (CEO of the Cancer Institute of NSW; Professor at Flinders University (SA) and an Honorary Professor of Sydney University and the University of Technology, Sydney, NSW)
David’s career has been an exercise in commitment to improving the quality of care for people at the end of their lives. His impact is evident in policy and service development, research and teaching throughout Australia and the world. With more than 240 publications to his name, David was recently rated one of the top 10 most published palliative care researchers in the world.
Prof. Trevor Williams (Monash University, Melbourne, Victoria)
A tenured Professor and Clinical Director of the Department of Allergy, Immunology and Respiratory Medicine at the Alfred Hospital in Melbourne. Special interests in the area of severe lung diseases including lung transplantation, particularly immunopathology of chronic rejection, pulmonary hypertension, exercise limitation in severe lung disease and development of novel bronschoscopic approaches to emphysema.
Prof. David Gordon (Flinders University, South Australia)
Head of Microbiology and Infectious Diseases t and Professor at Flinders University. Chief Examiner in Microbiology for the Royal College of Pathologists from 2001-2006 and initiator of the joint Microbiology and Infectious Diseases training program with the College of Physicians. His research interests include quality use of pathology, structural/functional analysis of complement regulatory proteins and disease-associated polymorphisms, bacterial pathogenesis and clinical studies of vaccine adjuvants.
Prof. Hubertus Jersmann (Adelaide University, SA)
Senior Respiratory and Sleep Consultant at the Royal Adelaide Hospital with interest in interventional pulmonology. Teaching coordinator for Respiratory Medicine at the University of Adelaide.
Assoc. Prof. Ken Pittman (University of Adelaide, South Australia)
Clinical Associate Professor within the Faculty of Medicine at the University of Adelaide. Visiting Medical Oncologist at Royal Adelaide Hospital, Calvary Hospital North Adelaide, Western Hospital Henley Beach and Whyalla Hospital. Member of several national cancer advisory boards. He is an active participant in student teaching, postgraduate education and clinical research.
Assoc. Prof. Geraint Rogers (SAHMRI & Flinders University, Adelaide, SA)
Director of Microbiome Research at the South Australian Health and Medical Research Institute (SAHMRI) Infection and Immunity Theme, and Associate Professor at the Flinders School of Medicine. Co-Convenor of the TSANZ Respiratory Infectious Disease Special Interest Group, Associate Editor of the Journal of Cystic Fibrosis. He has a longstanding research focus on complex microbial systems in chronic lung diseases, with present research activities centring on the use of microbiota profiling to personalise therapy.
Prof. Chris Karapetis (Flinders University, South Australia)
Director of Clinical Research / Senior Consultant Medical Oncologist at Flinders Medical Centre. Extensive clinical experience and research interest in thoracic oncology.
Dr Carmel Harrington (University of Sydney, NSW)
PhD in Sleep Medicine, Honorary Research Fellow, Westmead Hospital, Sydney. Director, Sleep for Health.
Dr Nicole Goh (Austin Health and Alfred Health, VIC)
Completed her PhD at the Imperial College in London in 2008 and explored the prognostic markers in scleroderma lung. Her research interest is in Interstitial Lung Diseases (ILD), focussing on measures of improved quality of life. Member of the Steering Committee of the National Idiopathic Pulmonary Fibrosis (IPF) Registry. Chair of IBAS’ Medical and Scientific Research Committee.
Dr Dion Grosser (University of Adelaide, South Australia)
Senior Respiratory and Sleep Physician at the Queen Elizabeth Hospital and Ashford Private Hospital. Extensive clinical experience in endobronchial interventions, ultrasound imaging of the thorax, and research interest in airways diseases. Specific interest in all areas of therapeutic bronchoscopy and pulmonary intervention including bronchoscopic lung volume reduction.
Dr Jeff Bowden (Flinders University, SA)
Director, Department of Respiratory and Sleep Medicine, Southern Adelaide Local Health Network (Inc. Flinders Medical Centre); Senior Lecturer at Flinders University. Medical Director at the Australian Respiratory and Sleep Medicine Institute (ARASMI).
Assoc. Prof. Dimitar Sajkov (Flinders University, South Australia)
Founding Director and CEO of the Australian Respiratory and Sleep Medicine Institute (ARASMI). CHEST Global Governor for Australia. Director of Southern Sleep service in Adelaide. Senior Consultant, Department of Respiratory and Sleep Medicine, Southern Adelaide Local Health Network. Senior Lecturer at Flinders University. Wide research interest, including pulmonary hypertension, COPD, sleep apnoea and respiratory vaccines
Prof. Gerard Silvestri (Medical University of South Carolina, US)
Hillenbrand Professor of Thoracic Oncology, Vice-Chair of Medicine for Faculty Development, Division of Pulmonary and Critical Care Medicine, Professor of Medicine, President of the American College of Chest Physicians (CHEST). He has experience in evaluating new technologies for the diagnosis and staging of lung cancer and was the part of the first group to publish the utility of endoscopic ultrasound with fine needle aspiration of mediastinal lymph nodes to stage lung cancer patients. The focus of his research is into evaluation and management of screen detected abnormalities, the ability to predict malignancy from a radiographically detected nodule, and the health policy implications of a mass screening program. He has developed a national and international reputation in lung cancer.
Prof. Atul C. Mehta (Lerner College of Medicine; Cleveland Clinic, Ohio, USA) Professor of Medicine, Lerner College of Medicine. Staff Physician, Respiratory Institute at Cleveland Clinic, Ohio. Dr. Mehta was the founder and president of the American Association for Bronchology and Senior Editor, Journal of Bronchology & Interventional Pulmonology. His research interests are diagnostic and therapeutic bronchoscopy and lung transplantation. He has published over 350 peer reviewed papers and over 75 book chapters. He’s edited 13 books and authored one, in the field of diagnostic and therapeutic bronchology.
Prof. Barbara Phillips (University of Kentucky, College of Medicine, Lexington, Kentucky, USA)
Professor of Pulmonary, Critical Care, and Sleep Medicine at the University of Kentucky, College of Medicine, Lexington. Barbara established and directs the University of Kentucky Sleep Center and is a past-chairman of the National Sleep Foundation and the American Board of Sleep Medicine. She is current President and Regent at Large of the American College of Chest Physicians. Barbara has served on the boards of the American Lung Association, the American Academy of Sleep Medicine, the Medical Advisory Board of the Federal Motor Carrier Safety Administration, and the Advisory Board to the National Center on Sleep Disorders Research. She received a Sleep Academic Award from the National Institutes of Health and an Excellence in Education Award from the American Academy of Sleep Medicine.
Prof. Christine McDonald (University of Melbourne, Victoria)
Director, Department of Respiratory and Sleep Medicine, and Chief Executive Officer, Institute for Breathing and Sleep, Austin Health, Heidelberg, Victoria. Research interests include non-pharmacological management of chronic lung diseases including COPD, interstitial lung diseases and lung cancer. Christine is Chair of the COPD Coordinating Committee and member of the COPD Guidelines Committee, Lung Foundation Australia and lead author of the TSANZ Position Paper on Provision of Adult Domiciliary Oxygen Therapy.
Prof. James Paton (University of Adelaide, South Australia)
Director, Research Centre for Infectious Diseases, School of Molecular and Biomedical Science and NHMRC Senior Principal Research Fellow. Fellow to the Australian Academy of Science since 2013. For 35 years his research has been focused on the fundamental molecular events involved in the interactions between pathogenic bacteria and their hosts, with particular reference to Streptococcus pneumoniae. A leading proponent of protein-based pneumococcal vaccines. To date, he has published over 340 scientific papers and book chapters.
Prof. Paul Reynolds (University of Adelaide, South Australia)
Clinical Director – Central Adelaide Local Health Network. Senior Respiratory and Sleep Consultant at the Royal Adelaide Hospital. Director – Basic and Translational Research Program, Lung Research Laboratory, Hanson Institute. Professor and NHMRC Practitioner Fellow, University of Adelaide. Past President of the Thoracic Society of Australia and New Zealand (TSANZ). Highly accomplished researcher with interest in asthma, inflammation and pulmonary hypertension.
Prof A. Simon Carney (Flinders University, South Australia)
Professor of ENT Surgery at Flinders University and was awarded his Doctorate for pioneering research into molecular changes in the nasal mucosa that precede the development of “hay-fever”. Between 2007 and 2011 he chaired the Flinders Clinical Research Ethics Committee and from 2005 to 2013 he was Head of the ENT Unit at FMC. He has written over 150 book chapters and publications in scientific journals and has been a faculty member at over 100 national and international meetings.
Assoc. Prof. Geoffrey Strange (University of Notre Dame, Western Australia)
CEO of the Pulmonary Hypertension Society Australia and New Zealand Inc. Geoff has been involved in several start-up biotechnology companies. He has a background in clinical cardiology and has a special interest in pulmonary hypertension. Geoff has more than 40 professional publications to his name, including books, peer review publications and abstracts presented at international scientific meetings. He has also been a speaker at many international scientific meetings held around the world.
Assoc. Prof. Jamie Triccas (University of Sydney)
Associate Professor Jamie Triccas is head of the Microbial Immunity and Pathogenesis Group located in the Department of Infectious Diseases and Immunology at the University of Sydney. He is a graduate of the University of Sydney and also trained at the Pasteur Institute in Paris, France. His work is focused on determining how virulent bacteria promote disease, and developing novel strategies to prevent infection. Over the last 10 years he has focused his efforts on the development of new tuberculosis vaccines and drugs, and a number of these candidates are nearing clinical trials in humans.
Dr Andrew Webster (University of WA, Perth Western Australia)
Andrew graduated from University of Glasgow and moved to Australia and underwent advanced training in Respiratory and Sleep Medicine at the Royal Adelaide Hospital, St Vincent’s Hospital including Advanced Lung Diseases and Transplantation and the Royal Prince Alfred Hospital. He obtained his FRACP in 2006. He subsequently obtained a research grant and spent three years as a Research Fellow in Advanced Lung Disease. He completed further training in Sleep Medicine at Sir Charles Gairdner Hospital including the Graduate Certificate in Sleep Science from the UWA. He worked there as a Consultant Sleep Physician and started his own practice in Mandurah three years ago. He is the Consultant Physician for Sleep Australia and also consults at Derbarl Yerrigan Aboriginal Health service in Perth. Andrew has a special interest in sleep disorders associated with psychiatric disorders. He actively participates in the meetings conducted by the Neurosciences Council of the ASA and is an associate researcher at the Institute for Respiratory Health.
Dr Jeremy Wrobel (Murdoch University of Perth, Western Australia)
Dr Wrobel is a Melbourne-trained respiratory physician. He completed his PhD in 2013, titled “The pathophysiology of pulmonary hypertension in COPD”. In 2013 he moved to Perth and now works at Fiona Stanley Hospital, specialising in lung transplantation, pulmonary hypertension and interstitial lung disease. He is a board member of the Pulmonary Hypertension Society of Australia and New Zealand and is deputy convener for the Orphan lung disease, Transplant, Interstitial and Vascular (OLIV) special interest group of the TSANZ.
Mr Leslie Jamieson (Adelaide Accounting Services Pty Ltd, South Australia)
Chartered accountant and Director of Adelaide Accounting Services. Extensive experience in planning and running specialist medical practises and taxation planning. Past experience in Australian Treasury, ATO auditor and accountancy consulting.